Ravi Mahalingam
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Herpesvirus 3, Human | 65 | 2022 | 381 | 6.330 |
Why?
| Varicellovirus | 13 | 2022 | 26 | 4.120 |
Why?
| Chickenpox | 19 | 2022 | 94 | 3.330 |
Why?
| Herpes Zoster | 29 | 2022 | 333 | 2.790 |
Why?
| Herpesviridae Infections | 11 | 2021 | 138 | 2.280 |
Why?
| Ganglia | 13 | 2019 | 29 | 2.150 |
Why?
| DNA, Viral | 33 | 2021 | 351 | 1.700 |
Why?
| Virus Latency | 13 | 2013 | 80 | 1.510 |
Why?
| Virus Activation | 13 | 2020 | 78 | 1.480 |
Why?
| Gene Expression Regulation, Viral | 4 | 2018 | 80 | 1.330 |
Why?
| Open Reading Frames | 6 | 2018 | 116 | 1.310 |
Why?
| Exanthema | 5 | 2022 | 77 | 1.040 |
Why?
| Monkey Diseases | 3 | 2018 | 19 | 0.980 |
Why?
| Genes, Viral | 12 | 2011 | 89 | 0.890 |
Why?
| Disease Models, Animal | 8 | 2019 | 3580 | 0.860 |
Why?
| Macaca mulatta | 6 | 2022 | 132 | 0.750 |
Why?
| Viral Envelope Proteins | 6 | 2020 | 74 | 0.700 |
Why?
| Trigeminal Ganglion | 7 | 1999 | 21 | 0.670 |
Why?
| Viral Tropism | 1 | 2019 | 24 | 0.660 |
Why?
| Green Fluorescent Proteins | 4 | 2018 | 377 | 0.660 |
Why?
| Immediate-Early Proteins | 4 | 2012 | 53 | 0.650 |
Why?
| Nervous System Diseases | 5 | 2013 | 253 | 0.610 |
Why?
| Genome, Viral | 5 | 2011 | 121 | 0.590 |
Why?
| Macaca fascicularis | 4 | 2021 | 51 | 0.560 |
Why?
| Animals | 43 | 2022 | 32102 | 0.550 |
Why?
| Neuralgia, Postherpetic | 4 | 2013 | 44 | 0.500 |
Why?
| Herpes Zoster Oticus | 3 | 2010 | 5 | 0.490 |
Why?
| Haplorhini | 7 | 2009 | 60 | 0.480 |
Why?
| Viral Proteins | 8 | 2018 | 286 | 0.470 |
Why?
| Tacrolimus | 3 | 2020 | 143 | 0.450 |
Why?
| Immunosuppressive Agents | 4 | 2020 | 666 | 0.440 |
Why?
| Ganglia, Sympathetic | 4 | 2001 | 18 | 0.440 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 45 | 0.420 |
Why?
| Antibodies, Viral | 10 | 2012 | 527 | 0.410 |
Why?
| Herpesvirus 1, Cercopithecine | 3 | 2002 | 3 | 0.410 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2014 | 193 | 0.400 |
Why?
| Polymerase Chain Reaction | 15 | 2007 | 1001 | 0.400 |
Why?
| Molecular Sequence Data | 19 | 2012 | 2790 | 0.390 |
Why?
| Chromosomes, Artificial, Bacterial | 1 | 2011 | 18 | 0.380 |
Why?
| Luminescent Proteins | 3 | 2002 | 169 | 0.380 |
Why?
| Cell Line | 12 | 2018 | 2651 | 0.370 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2014 | 693 | 0.360 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2014 | 965 | 0.350 |
Why?
| Varicella Zoster Virus Infection | 2 | 2020 | 19 | 0.350 |
Why?
| Islet Amyloid Polypeptide | 2 | 2021 | 47 | 0.350 |
Why?
| Base Sequence | 16 | 2011 | 2114 | 0.340 |
Why?
| Promoter Regions, Genetic | 2 | 2005 | 1122 | 0.320 |
Why?
| Amyloid beta-Peptides | 2 | 2021 | 191 | 0.310 |
Why?
| Temporal Arteries | 2 | 2021 | 47 | 0.310 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 214 | 0.310 |
Why?
| Giant Cell Arteritis | 2 | 2021 | 48 | 0.310 |
Why?
| Transcriptome | 1 | 2013 | 736 | 0.300 |
Why?
| Terminal Repeat Sequences | 1 | 2007 | 14 | 0.290 |
Why?
| Encephalitis, Varicella Zoster | 3 | 2015 | 20 | 0.290 |
Why?
| Vero Cells | 4 | 2011 | 65 | 0.270 |
Why?
| Herpesvirus 1, Human | 2 | 2011 | 78 | 0.260 |
Why?
| Kidney | 4 | 2009 | 1207 | 0.260 |
Why?
| Neurons | 3 | 2011 | 1298 | 0.250 |
Why?
| Apoptosis | 3 | 2012 | 2377 | 0.240 |
Why?
| Antigens, Viral | 5 | 2021 | 177 | 0.240 |
Why?
| Simplexvirus | 3 | 1999 | 82 | 0.220 |
Why?
| Transcriptional Activation | 1 | 2005 | 340 | 0.220 |
Why?
| Vasculitis | 3 | 2002 | 71 | 0.220 |
Why?
| Facial Neuralgia | 1 | 2003 | 1 | 0.220 |
Why?
| 2-Aminopurine | 1 | 2003 | 10 | 0.220 |
Why?
| Virus Diseases | 3 | 2011 | 200 | 0.220 |
Why?
| Virus Replication | 2 | 2019 | 396 | 0.220 |
Why?
| Humans | 60 | 2021 | 115613 | 0.190 |
Why?
| Genetic Engineering | 1 | 2002 | 81 | 0.190 |
Why?
| Nodose Ganglion | 1 | 2001 | 6 | 0.190 |
Why?
| Viral Load | 2 | 2019 | 405 | 0.190 |
Why?
| Adrenal Glands | 1 | 2021 | 72 | 0.190 |
Why?
| Arteritis | 1 | 2021 | 27 | 0.190 |
Why?
| Deoxyribonuclease EcoRI | 1 | 2000 | 5 | 0.180 |
Why?
| Substance P | 1 | 2020 | 44 | 0.180 |
Why?
| Protein Biosynthesis | 4 | 2005 | 390 | 0.180 |
Why?
| Amyloid | 1 | 2021 | 82 | 0.180 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 104 | 0.180 |
Why?
| Astrocytes | 2 | 2020 | 163 | 0.180 |
Why?
| Prednisone | 2 | 2014 | 232 | 0.180 |
Why?
| Neuralgia | 3 | 2004 | 122 | 0.170 |
Why?
| Acyclovir | 5 | 2020 | 100 | 0.170 |
Why?
| Sigmodontinae | 1 | 2019 | 2 | 0.170 |
Why?
| Viremia | 2 | 2010 | 122 | 0.170 |
Why?
| Guinea Pigs | 1 | 2019 | 151 | 0.160 |
Why?
| Immunoglobulin G | 3 | 2011 | 781 | 0.160 |
Why?
| Cerebral Arteries | 3 | 2011 | 55 | 0.160 |
Why?
| Cloning, Molecular | 6 | 2000 | 523 | 0.160 |
Why?
| Facial Paralysis | 2 | 2011 | 17 | 0.150 |
Why?
| Stroke | 4 | 2021 | 1016 | 0.150 |
Why?
| Cerebrospinal Fluid | 3 | 2011 | 88 | 0.150 |
Why?
| Peptide Fragments | 1 | 2021 | 675 | 0.140 |
Why?
| RNA, Viral | 6 | 2007 | 565 | 0.130 |
Why?
| Virology | 2 | 2013 | 19 | 0.130 |
Why?
| Antibodies, Monoclonal | 3 | 2012 | 1265 | 0.130 |
Why?
| Immunocompromised Host | 2 | 2011 | 197 | 0.130 |
Why?
| Recombinant Fusion Proteins | 1 | 1998 | 616 | 0.130 |
Why?
| Sequence Homology, Amino Acid | 3 | 2012 | 352 | 0.130 |
Why?
| Leukocytosis | 2 | 2010 | 35 | 0.130 |
Why?
| Down-Regulation | 2 | 2009 | 601 | 0.120 |
Why?
| Transfection | 3 | 2011 | 866 | 0.120 |
Why?
| Time Factors | 6 | 2010 | 6165 | 0.120 |
Why?
| Amino Acid Sequence | 5 | 2012 | 2000 | 0.120 |
Why?
| Cytopathogenic Effect, Viral | 2 | 2011 | 16 | 0.120 |
Why?
| Ganglia, Spinal | 2 | 1991 | 42 | 0.120 |
Why?
| Middle Aged | 21 | 2021 | 27014 | 0.120 |
Why?
| Nervous System | 2 | 2007 | 63 | 0.120 |
Why?
| Immunohistochemistry | 3 | 2010 | 1642 | 0.120 |
Why?
| Fluorometry | 1 | 2013 | 19 | 0.110 |
Why?
| Electrophoresis, Capillary | 1 | 2013 | 21 | 0.110 |
Why?
| Trans-Activators | 1 | 1996 | 370 | 0.110 |
Why?
| Myelitis | 1 | 1994 | 88 | 0.110 |
Why?
| Lymphocytes | 1 | 1995 | 344 | 0.110 |
Why?
| Herpes Zoster Vaccine | 2 | 2012 | 159 | 0.110 |
Why?
| Aged | 19 | 2021 | 19255 | 0.100 |
Why?
| Cerebrovascular Disorders | 2 | 2008 | 82 | 0.100 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2012 | 15 | 0.100 |
Why?
| Antiviral Agents | 5 | 2020 | 649 | 0.100 |
Why?
| Spinal Cord Diseases | 2 | 2010 | 39 | 0.100 |
Why?
| Male | 27 | 2021 | 55968 | 0.100 |
Why?
| Immunologic Memory | 1 | 2014 | 314 | 0.100 |
Why?
| Leukocytes, Mononuclear | 4 | 2003 | 501 | 0.100 |
Why?
| Tunica Intima | 1 | 2011 | 78 | 0.090 |
Why?
| Transcription, Genetic | 4 | 1995 | 1310 | 0.090 |
Why?
| Herpes Simplex | 1 | 2011 | 88 | 0.090 |
Why?
| Antibodies, Neutralizing | 1 | 2012 | 222 | 0.090 |
Why?
| Skin | 2 | 2007 | 662 | 0.090 |
Why?
| Thymidine Kinase | 1 | 1990 | 14 | 0.090 |
Why?
| Oligonucleotide Probes | 4 | 1996 | 54 | 0.090 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 431 | 0.090 |
Why?
| Zoster Sine Herpete | 1 | 2010 | 3 | 0.090 |
Why?
| Neural Stem Cells | 1 | 2011 | 115 | 0.090 |
Why?
| RNA, Messenger | 4 | 2009 | 2574 | 0.080 |
Why?
| Central Nervous System Infections | 1 | 2010 | 36 | 0.080 |
Why?
| Glucocorticoids | 1 | 2014 | 552 | 0.080 |
Why?
| Aged, 80 and over | 10 | 2015 | 6419 | 0.080 |
Why?
| Gene Expression | 3 | 2020 | 1436 | 0.080 |
Why?
| Genes, Reporter | 2 | 2000 | 257 | 0.080 |
Why?
| DNA Primers | 4 | 1998 | 514 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 930 | 0.080 |
Why?
| Caspases | 1 | 2009 | 245 | 0.080 |
Why?
| Female | 21 | 2021 | 59932 | 0.080 |
Why?
| X-Rays | 1 | 2007 | 31 | 0.070 |
Why?
| Vascular Diseases | 1 | 2010 | 230 | 0.070 |
Why?
| Vasculitis, Central Nervous System | 1 | 2007 | 17 | 0.070 |
Why?
| Liver | 1 | 1995 | 1690 | 0.070 |
Why?
| Artificial Gene Fusion | 1 | 2005 | 4 | 0.070 |
Why?
| Luciferases | 1 | 2005 | 140 | 0.060 |
Why?
| Erythrocytes | 1 | 2010 | 589 | 0.060 |
Why?
| Neutrophils | 1 | 2010 | 1172 | 0.060 |
Why?
| Aging | 1 | 2014 | 1631 | 0.060 |
Why?
| Cells, Cultured | 3 | 2020 | 3914 | 0.060 |
Why?
| Cell Differentiation | 1 | 2011 | 1700 | 0.060 |
Why?
| Magnetic Resonance Imaging | 6 | 2010 | 3071 | 0.060 |
Why?
| Restriction Mapping | 3 | 1992 | 77 | 0.060 |
Why?
| Dysgeusia | 1 | 2003 | 1 | 0.060 |
Why?
| Hyperacusis | 1 | 2003 | 8 | 0.060 |
Why?
| Amitriptyline | 1 | 2003 | 21 | 0.050 |
Why?
| Scalp | 1 | 2003 | 29 | 0.050 |
Why?
| DNA, Complementary | 2 | 2021 | 258 | 0.050 |
Why?
| Up-Regulation | 1 | 2005 | 820 | 0.050 |
Why?
| Adult | 12 | 2011 | 30726 | 0.050 |
Why?
| Analgesics, Non-Narcotic | 1 | 2003 | 117 | 0.050 |
Why?
| Paraffin Embedding | 1 | 2021 | 21 | 0.050 |
Why?
| Tissue Fixation | 1 | 2021 | 28 | 0.050 |
Why?
| Formaldehyde | 1 | 2021 | 47 | 0.050 |
Why?
| Cerebrospinal Fluid Proteins | 2 | 1998 | 10 | 0.050 |
Why?
| Thorax | 2 | 1992 | 41 | 0.050 |
Why?
| Histological Techniques | 1 | 2021 | 40 | 0.050 |
Why?
| Immunity, Cellular | 1 | 2003 | 262 | 0.050 |
Why?
| Mutation | 1 | 2011 | 3364 | 0.050 |
Why?
| Whole-Body Irradiation | 1 | 2020 | 72 | 0.040 |
Why?
| Immunization | 1 | 2003 | 401 | 0.040 |
Why?
| Molecular Weight | 1 | 2000 | 329 | 0.040 |
Why?
| Herpesviridae | 2 | 2007 | 21 | 0.040 |
Why?
| Models, Theoretical | 1 | 2004 | 519 | 0.040 |
Why?
| Intracellular Space | 1 | 2020 | 68 | 0.040 |
Why?
| Sequence Alignment | 1 | 2000 | 327 | 0.040 |
Why?
| Recurrence | 3 | 2011 | 952 | 0.040 |
Why?
| Extracellular Space | 1 | 2020 | 122 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 975 | 0.040 |
Why?
| Central Nervous System Diseases | 1 | 2000 | 61 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 391 | 0.040 |
Why?
| Gene Expression Regulation | 1 | 1988 | 2353 | 0.040 |
Why?
| Peripheral Nerves | 1 | 1999 | 65 | 0.040 |
Why?
| Lung | 2 | 2011 | 3673 | 0.040 |
Why?
| Viral Fusion Proteins | 1 | 1998 | 20 | 0.040 |
Why?
| Indicators and Reagents | 1 | 1998 | 100 | 0.040 |
Why?
| Herpesvirus 4, Human | 2 | 1996 | 123 | 0.040 |
Why?
| Glutathione Transferase | 1 | 1998 | 95 | 0.040 |
Why?
| Encephalitis, Viral | 1 | 1998 | 39 | 0.040 |
Why?
| Peripheral Nervous System Diseases | 1 | 1999 | 120 | 0.040 |
Why?
| Risk | 1 | 2020 | 819 | 0.040 |
Why?
| Encephalitis | 2 | 2000 | 127 | 0.040 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1998 | 117 | 0.040 |
Why?
| Chronic Disease | 1 | 2003 | 1598 | 0.040 |
Why?
| Rabbits | 1 | 1998 | 752 | 0.040 |
Why?
| Autonomic Nervous System Diseases | 1 | 1996 | 27 | 0.030 |
Why?
| Glycoproteins | 2 | 1988 | 309 | 0.030 |
Why?
| Blotting, Western | 1 | 1998 | 1153 | 0.030 |
Why?
| Necrosis | 2 | 1998 | 210 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2021 | 1536 | 0.030 |
Why?
| Cerebral Arterial Diseases | 1 | 2015 | 42 | 0.030 |
Why?
| Escherichia coli | 1 | 1998 | 730 | 0.030 |
Why?
| In Situ Hybridization | 1 | 1995 | 298 | 0.030 |
Why?
| Immunoenzyme Techniques | 2 | 1992 | 193 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2003 | 4440 | 0.030 |
Why?
| Internationality | 1 | 2015 | 145 | 0.030 |
Why?
| Predictive Value of Tests | 2 | 2011 | 1805 | 0.030 |
Why?
| Tubulin | 1 | 1995 | 123 | 0.030 |
Why?
| Viral Structural Proteins | 1 | 1993 | 12 | 0.030 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1994 | 221 | 0.030 |
Why?
| Fluorescent Antibody Technique | 2 | 2011 | 398 | 0.030 |
Why?
| Neutralization Tests | 1 | 2012 | 63 | 0.030 |
Why?
| DNA Restriction Enzymes | 2 | 1992 | 54 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2012 | 154 | 0.030 |
Why?
| Acute Disease | 2 | 2011 | 914 | 0.030 |
Why?
| Epitope Mapping | 1 | 2012 | 51 | 0.030 |
Why?
| Nucleic Acid Hybridization | 2 | 1992 | 189 | 0.020 |
Why?
| Lung Diseases | 1 | 1998 | 710 | 0.020 |
Why?
| Cytotoxicity, Immunologic | 1 | 1992 | 198 | 0.020 |
Why?
| Sequence Deletion | 1 | 2012 | 167 | 0.020 |
Why?
| Organ Specificity | 1 | 1992 | 273 | 0.020 |
Why?
| Polyradiculopathy | 1 | 1991 | 3 | 0.020 |
Why?
| Codon | 2 | 1990 | 86 | 0.020 |
Why?
| Erythrocebus patas | 1 | 1991 | 1 | 0.020 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 57 | 0.020 |
Why?
| Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| Epitopes | 2 | 1990 | 438 | 0.020 |
Why?
| Hyperplasia | 1 | 2011 | 166 | 0.020 |
Why?
| Cosmids | 1 | 1990 | 6 | 0.020 |
Why?
| Sulfur Isotopes | 1 | 1990 | 4 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3468 | 0.020 |
Why?
| Gene Amplification | 1 | 1990 | 96 | 0.020 |
Why?
| Paramecium | 1 | 1990 | 2 | 0.020 |
Why?
| Comorbidity | 1 | 2015 | 1473 | 0.020 |
Why?
| Meningitis | 1 | 1991 | 74 | 0.020 |
Why?
| Inflammation | 1 | 2020 | 2500 | 0.020 |
Why?
| Myosin Heavy Chains | 1 | 2011 | 169 | 0.020 |
Why?
| Cranial Nerve Diseases | 1 | 2010 | 42 | 0.020 |
Why?
| Myocytes, Smooth Muscle | 1 | 2011 | 239 | 0.020 |
Why?
| Cell Count | 1 | 2010 | 305 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2012 | 1243 | 0.020 |
Why?
| Cerebral Angiography | 1 | 2009 | 111 | 0.020 |
Why?
| Actins | 1 | 2011 | 383 | 0.020 |
Why?
| Brain | 2 | 2009 | 2373 | 0.020 |
Why?
| Spinal Cord | 1 | 1991 | 351 | 0.020 |
Why?
| Phosphorylation | 2 | 1990 | 1571 | 0.020 |
Why?
| Prevalence | 1 | 2015 | 2265 | 0.020 |
Why?
| History, 21st Century | 1 | 2009 | 162 | 0.020 |
Why?
| Retinal Necrosis Syndrome, Acute | 1 | 2008 | 9 | 0.020 |
Why?
| Laboratories | 1 | 2009 | 95 | 0.020 |
Why?
| DNA, Mitochondrial | 1 | 1990 | 185 | 0.020 |
Why?
| Autoradiography | 1 | 1988 | 71 | 0.020 |
Why?
| History, 20th Century | 1 | 2009 | 273 | 0.020 |
Why?
| Binding Sites | 1 | 1990 | 1177 | 0.020 |
Why?
| Antidepressive Agents | 1 | 2008 | 195 | 0.020 |
Why?
| Fibroblasts | 1 | 2011 | 839 | 0.020 |
Why?
| Infant | 2 | 1996 | 7976 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2009 | 1357 | 0.020 |
Why?
| Infant, Newborn | 2 | 1992 | 5060 | 0.010 |
Why?
| Antigens, CD20 | 1 | 2002 | 28 | 0.010 |
Why?
| Lipopolysaccharide Receptors | 1 | 2002 | 81 | 0.010 |
Why?
| Risk Factors | 1 | 2015 | 8699 | 0.010 |
Why?
| Disease Progression | 1 | 2008 | 2418 | 0.010 |
Why?
| Base Composition | 2 | 1992 | 76 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2008 | 783 | 0.010 |
Why?
| Meningitis, Aseptic | 1 | 2000 | 15 | 0.010 |
Why?
| HIV Seropositivity | 1 | 1998 | 110 | 0.010 |
Why?
| Syndrome | 1 | 1998 | 339 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1997 | 150 | 0.010 |
Why?
| Tumor Virus Infections | 1 | 1996 | 41 | 0.010 |
Why?
| Denervation | 1 | 1996 | 19 | 0.010 |
Why?
| Treatment Outcome | 1 | 2010 | 9159 | 0.010 |
Why?
| Neurons, Afferent | 1 | 1996 | 88 | 0.010 |
Why?
| Adolescent | 2 | 2007 | 17903 | 0.010 |
Why?
| Mice | 1 | 2011 | 15052 | 0.010 |
Why?
| Demyelinating Diseases | 1 | 1995 | 75 | 0.010 |
Why?
| Low Back Pain | 1 | 1996 | 95 | 0.010 |
Why?
| Gene Library | 1 | 1994 | 117 | 0.010 |
Why?
| Electromyography | 1 | 1996 | 324 | 0.010 |
Why?
| Blood Proteins | 1 | 1996 | 238 | 0.010 |
Why?
| Motor Neurons | 1 | 1996 | 213 | 0.010 |
Why?
| Genetic Vectors | 1 | 1994 | 290 | 0.010 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 1992 | 17 | 0.010 |
Why?
| Viral Plaque Assay | 1 | 1992 | 24 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1994 | 1044 | 0.010 |
Why?
| Cell Transformation, Viral | 1 | 1992 | 24 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1992 | 138 | 0.010 |
Why?
| Microscopy, Electron | 1 | 1992 | 409 | 0.010 |
Why?
| Clone Cells | 1 | 1992 | 248 | 0.010 |
Why?
| Cauda Equina | 1 | 1991 | 8 | 0.010 |
Why?
| Glucose | 1 | 1996 | 904 | 0.010 |
Why?
| Cerebral Hemorrhage | 1 | 1991 | 96 | 0.010 |
Why?
| Fetal Blood | 1 | 1992 | 268 | 0.010 |
Why?
| Genetic Code | 1 | 1990 | 20 | 0.010 |
Why?
| Blotting, Northern | 1 | 1990 | 194 | 0.010 |
Why?
| Genes | 1 | 1990 | 224 | 0.010 |
Why?
| Immune Tolerance | 1 | 1991 | 332 | 0.010 |
Why?
| RNA, Transfer | 1 | 1990 | 119 | 0.010 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1992 | 630 | 0.000 |
Why?
| Glycosylation | 1 | 1988 | 133 | 0.000 |
Why?
| Precipitin Tests | 1 | 1988 | 90 | 0.000 |
Why?
| Sensitivity and Specificity | 1 | 1992 | 1718 | 0.000 |
Why?
| Antibody Specificity | 1 | 1988 | 176 | 0.000 |
Why?
| Blood Glucose | 1 | 1996 | 1824 | 0.000 |
Why?
| Phosphoproteins | 1 | 1988 | 304 | 0.000 |
Why?
| Age Factors | 1 | 1992 | 2907 | 0.000 |
Why?
| Vaccination | 1 | 1992 | 1210 | 0.000 |
Why?
| Pregnancy | 1 | 1992 | 5550 | 0.000 |
Why?
| Child, Preschool | 1 | 1992 | 9131 | 0.000 |
Why?
|
|
Mahalingam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|